Cargando…

Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010

Detalles Bibliográficos
Autores principales: Fairman, Kathleen A., Curtiss, Frederic R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438351/
https://www.ncbi.nlm.nih.gov/pubmed/20866167
http://dx.doi.org/10.18553/jmcp.2010.16.8.629
_version_ 1785092772831690752
author Fairman, Kathleen A.
Curtiss, Frederic R.
author_facet Fairman, Kathleen A.
Curtiss, Frederic R.
author_sort Fairman, Kathleen A.
collection PubMed
description
format Online
Article
Text
id pubmed-10438351
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104383512023-08-21 Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010 Fairman, Kathleen A. Curtiss, Frederic R. J Manag Care Pharm Editorials Academy of Managed Care Pharmacy 2010-10 /pmc/articles/PMC10438351/ /pubmed/20866167 http://dx.doi.org/10.18553/jmcp.2010.16.8.629 Text en Copyright © 2010, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Editorials
Fairman, Kathleen A.
Curtiss, Frederic R.
Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
title Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
title_full Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
title_fullStr Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
title_full_unstemmed Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
title_short Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
title_sort regulatory actions on the off-label use of prescription drugs: ongoing controversy and contradiction in 2009 and 2010
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438351/
https://www.ncbi.nlm.nih.gov/pubmed/20866167
http://dx.doi.org/10.18553/jmcp.2010.16.8.629
work_keys_str_mv AT fairmankathleena regulatoryactionsontheofflabeluseofprescriptiondrugsongoingcontroversyandcontradictionin2009and2010
AT curtissfredericr regulatoryactionsontheofflabeluseofprescriptiondrugsongoingcontroversyandcontradictionin2009and2010